6:08 PM
 | 
Nov 02, 2012
 |  BC Extra  |  Financial News

Vertex falls after earnings miss

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) fell $5.47 (11%) to $45.01 on Friday after reporting 3Q12 earnings late Thursday that missed the Street's revenue and EPS estimates. The move translates into a $1.2 billion loss...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >